APA (7th ed.) Citation

Low, S. K., Fujiwara, Y., Nishizaki, D., Kato, S., & Kurzrock, R. (2026). Class II Major Histocompatibility Complex Transactivator (CIITA): A Master MHC-II Regulator Impacting Cancer and Beyond. Journal of Immunotherapy & Precision Oncology, 9(2), 36. https://doi.org/10.36401/JIPO-25-31

Chicago Style (17th ed.) Citation

Low, Soon Khai, Yu Fujiwara, Daisuke Nishizaki, Shumei Kato, and Razelle Kurzrock. "Class II Major Histocompatibility Complex Transactivator (CIITA): A Master MHC-II Regulator Impacting Cancer and Beyond." Journal of Immunotherapy & Precision Oncology 9, no. 2 (2026): 36. https://doi.org/10.36401/JIPO-25-31.

MLA (9th ed.) Citation

Low, Soon Khai, et al. "Class II Major Histocompatibility Complex Transactivator (CIITA): A Master MHC-II Regulator Impacting Cancer and Beyond." Journal of Immunotherapy & Precision Oncology, vol. 9, no. 2, 2026, p. 36, https://doi.org/10.36401/JIPO-25-31.